Advances in migraine management: implications for managed care organizations.

Medicine & Life Sciences

• Managed Care Programs 100%
• Migraine Disorders 87%
• Tryptamines 82%
• Organizations 72%
• Costs and Cost Analysis 18%
• Therapeutics 14%
• Economic Models 13%
• Serotonin Receptor Agonists 12%
• Serotonin Receptors 11%
• Budgets 11%
• Health Expenditures 9%
• Patient Satisfaction 9%
• Quality of Life 6%
• Delivery of Health Care 5%

Social Sciences

• managed care 98%
• costs 49%
• management 41%
• course of a disease 35%
• appropriate treatment 29%
• economic model 25%
• expenditures 19%
• medication 18%
• quality of life 17%
• budget 17%
• health care 15%